Abstract
Interferon-alpha therapy and the IL-18 pathway in chronic hepatitis C patients: IFN-alpha therapy enhances circulating IL-18 binding protein levels
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
